IRIS
GALIERO, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.124
AS - Asia 1.560
NA - Nord America 1.104
SA - Sud America 199
AF - Africa 18
Totale 6.005
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.538
US - Stati Uniti d'America 1.070
SG - Singapore 484
CN - Cina 346
VN - Vietnam 247
IT - Italia 231
HK - Hong Kong 229
BR - Brasile 167
IE - Irlanda 123
KR - Corea 79
IN - India 72
DE - Germania 71
GB - Regno Unito 29
JP - Giappone 27
FR - Francia 23
NL - Olanda 16
MX - Messico 14
PL - Polonia 13
CA - Canada 12
AT - Austria 11
ID - Indonesia 11
FI - Finlandia 10
AR - Argentina 9
BD - Bangladesh 9
LT - Lituania 8
ZA - Sudafrica 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
TR - Turchia 7
UA - Ucraina 7
CO - Colombia 6
PK - Pakistan 6
PT - Portogallo 5
SE - Svezia 5
VE - Venezuela 5
CH - Svizzera 4
EC - Ecuador 4
ES - Italia 4
IL - Israele 4
IQ - Iraq 4
MA - Marocco 4
SA - Arabia Saudita 4
BE - Belgio 3
BO - Bolivia 3
CR - Costa Rica 3
IR - Iran 3
PE - Perù 3
AZ - Azerbaigian 2
EG - Egitto 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
UZ - Uzbekistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
HR - Croazia 1
JO - Giordania 1
LB - Libano 1
LV - Lettonia 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PY - Paraguay 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
Totale 6.005
Salva come PNG Salva come JPEG
Città #
Moscow 906
Singapore 243
San Jose 236
Hong Kong 222
Santa Clara 126
Dublin 117
Hefei 98
Ashburn 91
The Dalles 82
Seoul 79
Naples 74
Ho Chi Minh City 73
New York 57
Hanoi 56
Bengaluru 47
Chandler 43
Munich 34
Beijing 33
Los Angeles 33
Dallas 23
São Paulo 20
Da Nang 19
Memphis 14
Orem 14
Haiphong 12
Amsterdam 11
Atlanta 9
Avellino 9
Chicago 9
Salerno 9
Falkenstein 8
Frankfurt am Main 8
Hillsboro 8
Hải Dương 8
Milan 8
Belo Horizonte 7
Brooklyn 7
Liveri 7
Mexico City 7
Warsaw 7
Bexley 6
Biên Hòa 6
Boardman 6
Cambridge 6
Chennai 6
Florence 6
Princeton 6
Roxbury 6
Vienna 6
Brno 5
Bến Tre 5
Denver 5
Ercolano 5
Helsinki 5
Johannesburg 5
Lahore 5
Manchester 5
Nuremberg 5
San Francisco 5
Stockholm 5
Tokyo 5
Boston 4
Bắc Ninh 4
Guarulhos 4
Istanbul 4
Lisbon 4
Montreal 4
Paris 4
Pelotas 4
Rio de Janeiro 4
Toronto 4
Wroclaw 4
Yên Bái 4
Zurich 4
Boydton 3
Brasília 3
Bremen 3
Brussels 3
Bắc Giang 3
Campinas 3
Can Tho 3
Cape Town 3
Council Bluffs 3
La Paz 3
Lappeenranta 3
London 3
Mumbai 3
New Delhi 3
Nha Trang 3
Ninh Bình 3
Olbia 3
Porto Alegre 3
Rome 3
San José 3
Shenzhen 3
Tel Aviv 3
Terzigno 3
Thanh Mỹ Tây 3
The Bronx 3
Thái Bình 3
Totale 3.118
Salva come PNG Salva come JPEG
Nome #
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 193
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 183
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 159
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 158
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 155
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 151
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 150
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 149
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 148
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 143
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 141
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 140
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 132
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 131
Liver Involvement in Patients With Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 131
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 131
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 130
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 127
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 127
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 125
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 124
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 124
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 124
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 123
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 118
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 116
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 115
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 115
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 114
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 113
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 111
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 111
The Significance of Statin-Associated Muscle Symptoms and Its Impact on Patient Adherence and Outcomes 111
Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom? 108
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 108
Polypharmacy and major adverse events in atrial fibrillation 108
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 107
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 104
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 99
NerveCheck master to screen patients with type 1 or type 2 diabetes for peripheral and cardiac autonomic neuropathy 99
The Role of Neuropathy Screening Tools in Patients Affected by Fibromyalgia 96
null 93
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 92
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study 90
The Role of Lung Ultrasound in SARS-CoV-19 Pneumonia Management 89
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 87
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 84
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 79
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 79
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience 70
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study 68
Totale 6.083
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.152
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202246 1 0 0 2 2 0 2 1 9 1 8 20
2022/2023221 11 12 4 10 27 11 5 8 105 10 7 11
2023/2024276 26 13 9 24 51 45 8 9 7 25 26 33
2024/2025967 4 14 3 24 154 95 123 92 164 102 88 104
2025/20264.573 247 300 240 145 401 2.333 318 203 165 103 90 28
Totale 6.083